ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PRM Proteome Sciences Plc

2.65
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.65 2.30 3.00 - 0.00 13:55:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 5.03M -2.44M -0.0083 -3.19 7.82M
Proteome Sciences Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome Sciences was 2.65p. Over the last year, Proteome Sciences shares have traded in a share price range of 2.30p to 5.50p.

Proteome Sciences currently has 295,182,056 shares in issue. The market capitalisation of Proteome Sciences is £7.82 million. Proteome Sciences has a price to earnings ratio (PE ratio) of -3.19.

Proteome Sciences Share Discussion Threads

Showing 157776 to 157798 of 158000 messages
Chat Pages: 6320  6319  6318  6317  6316  6315  6314  6313  6312  6311  6310  6309  Older
DateSubjectAuthorDiscuss
15/9/2024
09:12
Jibberish, no change.
emigna2020
15/9/2024
09:04
If Carlberg did deluded….
barry evans
15/9/2024
08:55
wasjobber

Good man ,ignore the M`Icke gang of scum.

emigna2020
15/9/2024
08:54
wasjobber, thank you.

I think it is important to explain that essentially there are two acquisition modes that mass specs use for proteomics data collection. DDA (Data Dependant Acquisition) mode and DIA (Data Independent Acquisition) mode. TMT reagents are only used for the DDA mode. Now Proteome Sciences have designed, patented and produced the first set of 6-plexDIA reagents for DIA mode, this now addresses a whole NEW MARKET of mass spec proteomics customers.

I believe the existing large base of DIA mode customers will be keen to use Proteome Sciences new 6-plexDIA reagents, with the prospects of the reagents rapidly expanding to 26-plex and probably more.

It will be interesting to see who Proteome Sciences sign a license deal with soon, as growth in the DIA user market will be rapid, from an existing large base of customers who are keen to multiplex their mass spec proteomics measurements.

pools2
15/9/2024
08:29
You mean #93060 presumably
bluemango
14/9/2024
20:27
>93059 - as in Chief Executive
suffolkhath
14/9/2024
16:53
Reliably unreliable - that you can rely on.
monte1
14/9/2024
16:45
"reliably"
jeffian
14/9/2024
16:22
If you actually read and understand the details of yesterdays RNS properly, the future looks better than ever. Proteome Sciences are about to grab the larger part of the mass spec proteomics tagging market by offering DIA users their new plex-DIA reagents, up to at least 26-plex. This is impressive.

DIA users are waiting for higher plexing reagents. With current reagents DIA users can only perform up to 3-plex measurements. Proteome Sciences offering 6-plex intially and then up to at least 26-plexDIA is a massive leap forward and something most if not all DIA users will want to use!

This is a new large untouched market for PRM's new plex-DIA reagents and it looks like they're going 'full on' to dominate it, much like the TMT-DDA market.

Add to that the new 32/35-plex TMTpro reagents now being shipped to eager customers, revenues will leap.

Add to that the new clinical biomarkers services contracts, some license fees, milestone fees and further running royalties, Proteome Sciences will be comfortably in profit.

Then there is the Alzheimers Disease IP and Cancer pathway IP. Watch this space closely!

STRONG BUY

wasjobber
14/9/2024
16:17
It's not over yet! PRM still have a business and IP that has some value. The immediate issue might be cash to get them through, nonetheless, this is a shocking disappointment, how did everything go so wrong ?.
049balt
13/9/2024
23:23
Tbf it actually bit the dust around 20 years ago, avatars simply wouldn’t accept it and increased their losses time and time again for a good decade or more since.
barry evans
13/9/2024
21:53
Another one bites the dust
suffolkhath
13/9/2024
11:48
I understand that Diane Abbott is crunching the numbers.
monte1
13/9/2024
11:20
Depressing when they can't even get the punctuation on the press release correct.. "In addition, the US lab in San Diego, has delivered its first projects.." I'm just hoping they are better with numbers ... eventually.
small crow
13/9/2024
11:11
Hand Massager Market size is estimated to register a CAGR of around 3.8% between 2024 & 2032.

To know more, visit :-

Key players are :- Aarogya Mandir
Lifepro
Comfier Massager Factory
Cotsoco

elpirata
13/9/2024
10:33
There re 3 sets of different 32plex reagents, and these can be used in such a way as to give 96plex. Together with 6 calibration channels as well. That is what is getting the industry excited.
goatherd
13/9/2024
10:31
I am sure I am not the only avatar to note the significance of the date of this RNS.

vbrs
J Voorhees

barry evans
13/9/2024
10:28
Thanks gnnmartin,

I recon on a good day at the right auction house my notepad could fetch more than all the sets of 20-plexDIA reagents put together.

barry evans
13/9/2024
10:01
Barry, gosh, what a long memory you have. As I wrote above, it was the hiring of Dr S. in 2021 that finally persuaded me to buy some PRM (on 24/4/2021).
gnnmartin
13/9/2024
09:59
Its probably Diggle posting in desperation, what between this pos & obd race to oblivion he needs snookers to get his money back
elpirata
13/9/2024
09:22
Proteome Sciences to make a set of 20-plexDIA reagents. This is remarkable.

This is massive news for the proteomics market and a game changer for DIA measurements, which are currently limited to just 3-plex.

pools2
13/9/2024
09:16
Oh hello

gross profit margin down from 50% to 10% so what else have they stuck in cost of sales?

trade & receivables down by 67% but no change in admin costs

Cash down by almost half to £1.2m

Theres a cash crunch coming Q1 2025 if not before

STRONG SELL

elpirata
13/9/2024
08:43
Morning G - long time no ‘see’.

Who would have thunk it eh?

A bit to go to get to the ‘next stop 10p then 30p’ never mind the goatfabled £53

And yet still being labelled a ‘strong buy’ from the braying avatar pools2/wasjobber even before todays 17% drop.

As for Mariola - it seems pretty clear to me (0), whether that was down to her or the duff hand she was dealt is another matter.

monte1
Chat Pages: 6320  6319  6318  6317  6316  6315  6314  6313  6312  6311  6310  6309  Older

Your Recent History

Delayed Upgrade Clock